Targeted therapies in leukemia

31 – 33 of 33

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/organization/v1001160?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
3
4
next »

2015
Mark Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS
Krönke, Jan ; Fink, Emma C. ; Hollenbach, Paul W. ; MacBeth, Kyle J. ; Hurst, Slater N. ; Udeshi, Namrata D. ; Chamberlain, Philip P. ; Mani, D. R. ; Man, Hon Wah and Gandhi, Anita K. , et al. (2015) In Nature 523(7559). p.183-188
- Contribution to journal › Article
2014
Mark Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia
Järås, Marcus ^LU ; Miller, Peter G. ; Chu, Lisa P. ; Puram, Rishi V. ; Fink, Emma C. ; Schneider, Rebekka K. ; Al-Shahrour, Fatima ; Peña, Pablo ^LU ; Breyfogle, L. Jordan and Hartwell, Kimberly A. , et al. (2014) In Journal of Experimental Medicine 211(4). p.605-612
- Contribution to journal › Article
2010
Mark Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein.
Järås, Marcus ^LU ; Johnels, Petra ^LU ; Hansen, Nils ^LU ; Ågerstam, Helena ^LU ; Tsapogas, Panagiotis ; Rissler, Marianne ^LU ; Lassen, Carin ^LU ; Olofsson, Tor ^LU ; Bjerrum, Ole Weis and Richter, Johan ^LU , et al. (2010) In Proceedings of the National Academy of Sciences 107(37). p.16280-16285
- Contribution to journal › Article

« previous
1
2
3
4
next »

Publications

Open access (%)

Authors/Editors

(23)
(12)
(11)
(9)
(8)
(8)
(8)
(7)
(6)
(6)
(6)
(5)
(5)
(5)
(4)
(4)
(4)
(4)
(3)
(3)
(3)
(3)
(3)
(3)
(3)
(3)
(3)
(3)
(3)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(2)

your query:: Remove department: Targeted therapies in leukemia